These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17344186)

  • 1. Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
    Graciano ML; Mouton CR; Patterson ME; Seth DM; Mullins JJ; Mitchell KD
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1858-66. PubMed ID: 17344186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension.
    Opay AL; Mouton CR; Mullins JJ; Mitchell KD
    Am J Physiol Renal Physiol; 2006 Sep; 291(3):F612-8. PubMed ID: 16622181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced tubuloglomerular feedback in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
    Mitchell KD; Mullins JJ
    Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1210-6. PubMed ID: 16033920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats.
    Howard LL; Patterson ME; Mullins JJ; Mitchell KD
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F810-5. PubMed ID: 15585671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension.
    Patterson ME; Mullins JJ; Mitchell KD
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F205-11. PubMed ID: 17977909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension.
    Patterson ME; Mouton CR; Mullins JJ; Mitchell KD
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F754-9. PubMed ID: 15900020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib ameliorates renal morphological changes in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
    Graciano ML; Mitchell KD
    Am J Physiol Renal Physiol; 2012 Jan; 302(1):F60-9. PubMed ID: 21975872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, in Cyp1a1-Ren2 transgenic rats.
    Ortiz RM; Graciano ML; Mullins JJ; Mitchell KD
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1584-91. PubMed ID: 17715265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct renin inhibition with aliskiren normalizes blood pressure in Cyp1a1-Ren2 transgenic rats with inducible angiotensin ii-dependent malignant hypertension.
    Howard CG; Mullins JJ; Mitchell KD
    Am J Med Sci; 2011 May; 341(5):383-7. PubMed ID: 21358304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AT1 receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyp1a1-Ren2 transgenic rats fed with a high-salt diet.
    Williams DE; Prieto MC; Mullins JJ; Navar LG; Mitchell KD
    Am J Med Sci; 2010 Apr; 339(4):356-61. PubMed ID: 20224314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient induction of ANG II-dependent malignant hypertension causes sustained elevation of blood pressure and augmentation of the pressor response to ANG II in CYP1A1-REN2 transgenic rats.
    Howard CG; Mullins JJ; Mitchell KD
    Am J Med Sci; 2010 Jun; 339(6):543-8. PubMed ID: 20375689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced urinary angiotensinogen excretion in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
    Milani CJ; Kobori H; Mullins JJ; Mitchell KD
    Am J Med Sci; 2010 Nov; 340(5):389-94. PubMed ID: 20724906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension.
    Prieto MC; Williams DE; Liu L; Kavanagh KL; Mullins JJ; Mitchell KD
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F581-8. PubMed ID: 21068087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient renin-angiotensin system stimulation in an early stage of life causes sustained hypertension in rats.
    Heijnen BF; Peutz-Kootstra CJ; Mullins JJ; Janssen BJ; Struijker-Boudier HA
    J Hypertens; 2011 Dec; 29(12):2369-80. PubMed ID: 22025236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Vanourková Z; Erbanová M; Thumová M; Opocenský M; Mullins JJ; Kramer HJ; Bürgelová M; Cervenka L
    J Hypertens; 2010 Mar; 28(3):495-509. PubMed ID: 19927008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis.
    Peters B; Grisk O; Becher B; Wanka H; Kuttler B; Lüdemann J; Lorenz G; Rettig R; Mullins JJ; Peters J
    J Hypertens; 2008 Jan; 26(1):102-9. PubMed ID: 18090546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension.
    Vanourková Z; Kramer HJ; Husková Z; Vanecková I; Opocenský M; Chábová VC; Tesar V; Skaroupková P; Thumová M; Dohnalová M; Mullins JJ; Cervenka L
    J Hypertens; 2006 Dec; 24(12):2465-72. PubMed ID: 17082731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal functional responses to selective intrarenal renin inhibition in Cyp1a1-Ren2 transgenic rats with ANG II-dependent malignant hypertension.
    Howard CG; Mitchell KD
    Am J Physiol Renal Physiol; 2012 Jan; 302(1):F52-9. PubMed ID: 21993885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.